DIANT Pharma Inc.
PrivateLast Round
Crowdfunding
May 8, 2025
Est. Valuation
$16.25M
Total Funding Raised
$3.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DIANT Pharma Inc. is a biotechnology company that provides continuous, process-controlled manufacturing platforms and services for nanoparticle production.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Smart Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DIANT Pharma Inc. Comparables
Compare DIANT Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inside Therapeutics | 82% | |
| Danaher | 78% | |
| KNAUER Wissenschaftliche Geräte GmbH | 73% |
DIANT Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | May 8, 2025 | ||||
| Seed | Mar 12, 2025 | ||||
| Seed | Mar 27, 2023 | ||||
| Pre Seed | Jan 20, 2023 | ||||
| Grant | Feb 15, 2022 | ||||
Convertible Debt | Oct 28, 2021 |
Key People
Founding team and executive leadership
DIANT Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Convertible Debt, Pre Seed, Seed |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 157% MoM, reaching 393.
- Oct 1, 2025
Attending the ISPE Product Show on October 1st, 2025.
DIANT Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DIANT Pharma Inc.'s valuation, stock price, and market status.
Is DIANT Pharma Inc. a public or private company?
DIANT Pharma Inc. is a private company.
What is the current stock price of DIANT Pharma Inc.?
DIANT Pharma Inc. is a private company, so its shares have no public market price. Caplight tracks DIANT Pharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DIANT Pharma Inc. worth (valuation)?
DIANT Pharma Inc.'s valuation is estimated at $16.3M based on funding round data.
Can I buy DIANT Pharma Inc. stock?
DIANT Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DIANT Pharma Inc.'s last funding round?
DIANT Pharma Inc.'s most recent funding round was Crowdfunding on May 8, 2025.
Who are the main investors in DIANT Pharma Inc.?
Key investors in DIANT Pharma Inc. include Connecticut Innovations, National Science Foundation.
Will DIANT Pharma Inc. IPO soon?
No public IPO plans have been announced for DIANT Pharma Inc..
How can I track DIANT Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DIANT Pharma Inc.'s shares on secondary markets.